Jove
Visualize
Contact Us

Related Concept Videos

Viral Recombination00:57

Viral Recombination

24.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.9K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

440
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
440
Infection01:20

Infection

11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

470
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
470
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

917
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
917
Viral Mutations00:36

Viral Mutations

39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dengue and chikungunya virus transmission in Kinshasa, Democratic Republic of the Congo.

medRxiv : the preprint server for health sciences·2026
Same author

Comparable Neutralizing Antibody Responses Following JN.1 and KP.2-Based COVID-19 Vaccination Suggest Limited Added Value of Minor Strain Updates: A Multicentre Immunogenicity Study.

Influenza and other respiratory viruses·2026
Same author

Integrated Surveillance Strategies and Clinical Characteristics of Arboviral Diseases in a Pediatric Cohort in Merida, Mexico, 2021-2023.

The American journal of tropical medicine and hygiene·2026
Same author

Yellow Fever in Pregnancy: A Comprehensive Review of the Clinical Implications and Vaccination in the Context of the 2024-2026 Americas Outbreak.

Tropical medicine and infectious disease·2026
Same author

Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.

The New England journal of medicine·2026
Same author

Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.

Nature microbiology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 10, 2026

Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus
10:35

Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus

Published on: May 31, 2020

3.4K

Update on emerging and re-emerging vector-borne diseases.

Courtney A Micheletti1, Michael W Crawford1, William B Messer2

  • 1Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA.

The American Journal of the Medical Sciences
|November 28, 2025
PubMed
Summary
This summary is machine-generated.

Vector-borne diseases (VBDs), transmitted by ticks and mosquitoes, are a growing global health threat. This article highlights recent advances in understanding and combating these escalating RNA virus infections.

Keywords:
ArbovirusesEmerging infectious diseasesVector-borne diseases

More Related Videos

Experimental Viral Infection in Adult Mosquitoes by Oral Feeding and Microinjection
08:02

Experimental Viral Infection in Adult Mosquitoes by Oral Feeding and Microinjection

Published on: July 28, 2022

2.8K
Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing
07:21

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Published on: August 25, 2018

13.3K

Related Experiment Videos

Last Updated: Jan 10, 2026

Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus
10:35

Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus

Published on: May 31, 2020

3.4K
Experimental Viral Infection in Adult Mosquitoes by Oral Feeding and Microinjection
08:02

Experimental Viral Infection in Adult Mosquitoes by Oral Feeding and Microinjection

Published on: July 28, 2022

2.8K
Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing
07:21

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Published on: August 25, 2018

13.3K

Area of Science:

  • Public Health
  • Virology
  • Epidemiology

Background:

  • Vector-borne diseases (VBDs) represent a significant and increasing global health challenge.
  • The incidence of vector-borne RNA viruses has risen, encompassing diverse genera like dengue and newly identified orthonairoviruses.
  • Complex ecological, environmental, immunological, and socioeconomic factors influence VBD transmission dynamics.

Purpose of the Study:

  • To highlight major and recent findings concerning vector-borne RNA viruses.
  • To present novel discoveries and insights into VBDs.
  • To inform current clinical management and public health control strategies for emerging VBDs.

Main Methods:

  • Review of select viruses and concepts in VBDs.
  • Prioritization of major and recent findings.
  • Analysis of factors influencing transmission and challenges in control.

Main Results:

  • Increased incidence of vector-borne RNA viruses globally.
  • Identification of diverse viral genera, including dengue, Oropouche virus, and orthonairoviruses.
  • Recognition of complex factors challenging diagnosis, management, and prevention.

Conclusions:

  • Emerging vector-borne RNA viruses pose a persistent threat.
  • Novel discoveries are crucial for updating clinical and public health approaches.
  • Integrated strategies are needed to combat the escalating VBD epidemic.